Conditional Global-First Nod For SanBio's Cell Therapy for TBI

But Product Consistency Challenge Looms

 
• By Lisa Takagi
  
SanBio's Akuugo can be the global first pharmaceutical product approved for TBI treatment.
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia